Markus Hammer

1.0k total citations
32 papers, 769 citations indexed

About

Markus Hammer is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Markus Hammer has authored 32 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in Markus Hammer's work include Immune Cell Function and Interaction (11 papers), Cytomegalovirus and herpesvirus research (10 papers) and T-cell and B-cell Immunology (10 papers). Markus Hammer is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Cytomegalovirus and herpesvirus research (10 papers) and T-cell and B-cell Immunology (10 papers). Markus Hammer collaborates with scholars based in Germany, United States and Croatia. Markus Hammer's co-authors include Petra Reinke, Hans‐Dieter Volk, Nina Babel, Gordon Brestrich, H. Lehmkuhl, Peter Nickel, Armin Kurtz, Г. В. Черепнев, Annika Fischer and Hashim Abdul‐Khaliq and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of the American Society of Nephrology.

In The Last Decade

Markus Hammer

32 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Hammer Germany 18 291 289 252 120 100 32 769
Ellen Fietze Germany 13 323 1.1× 406 1.4× 208 0.8× 74 0.6× 186 1.9× 25 1.2k
E. C. Benton United Kingdom 16 319 1.1× 614 2.1× 73 0.3× 11 0.1× 121 1.2× 35 979
Fabrice Larosa France 17 144 0.5× 309 1.1× 112 0.4× 54 0.5× 26 0.3× 36 780
Dorothy Hui Lin Ng Singapore 10 80 0.3× 79 0.3× 570 2.3× 29 0.2× 34 0.3× 19 953
Raymond C. Yu United Kingdom 14 149 0.5× 242 0.8× 213 0.8× 9 0.1× 233 2.3× 36 901
B. Catteau France 17 110 0.4× 230 0.8× 101 0.4× 9 0.1× 82 0.8× 50 719
Takaharu Matsuyama Japan 17 711 2.4× 426 1.5× 232 0.9× 23 0.2× 80 0.8× 34 1.4k
Susan DeWolf United States 16 157 0.5× 170 0.6× 469 1.9× 289 2.4× 132 1.3× 27 952
Jennifer Cuellar‐Rodríguez United States 16 108 0.4× 333 1.2× 339 1.3× 24 0.2× 42 0.4× 48 1.1k
Marie‐Thérèse Rubio France 19 326 1.1× 196 0.7× 445 1.8× 38 0.3× 69 0.7× 58 1.1k

Countries citing papers authored by Markus Hammer

Since Specialization
Citations

This map shows the geographic impact of Markus Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hammer more than expected).

Fields of papers citing papers by Markus Hammer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hammer. The network helps show where Markus Hammer may publish in the future.

Co-authorship network of co-authors of Markus Hammer

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Hammer. A scholar is included among the top collaborators of Markus Hammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Hammer. Markus Hammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erdur, Hebun, Mathias Streitz, Markus Hammer, et al.. (2016). EBNA1 antigen-specific CD8 + T cells in cerebrospinal fluid of patients with multiple sclerosis. Journal of Neuroimmunology. 294. 14–17. 5 indexed citations
2.
Fischer, Annika, Gordon Brestrich, Marcin W. Włodarski, et al.. (2011). Cytomegalovirus-Specific Regulatory and Effector T Cells Share TCR Clonality—Possible Relation to Repetitive CMV Infections. American Journal of Transplantation. 12(3). 669–681. 40 indexed citations
3.
Brestrich, Gordon, Annika Fischer, Markus Hammer, et al.. (2009). Adoptive T-Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy. American Journal of Transplantation. 9(7). 1679–1684. 81 indexed citations
4.
Brestrich, Gordon, Andy Roemhild, Michel Noutsias, et al.. (2009). Generation of HCMV-specific T-cell Lines From Seropositive Solid-organ-transplant Recipients for Adoptive T-cell Therapy. Journal of Immunotherapy. 32(9). 932–940. 17 indexed citations
5.
Hoeflich, Conny, Nadine Unterwalder, Kathrin Schmolke, et al.. (2009). Clinical manifestation of mannose-binding lectin deficiency in adults independent of concomitant immunodeficiency. Human Immunology. 70(10). 809–812. 16 indexed citations
6.
Babel, Nina, Gordon Brestrich, Lukasz P. Gondek, et al.. (2008). Clonotype Analysis of Cytomegalovirus-Specific Cytotoxic T Lymphocytes. Journal of the American Society of Nephrology. 20(2). 344–352. 18 indexed citations
7.
Babel, Nina, Athanasios Vergopoulos, Ralf Ulrich Trappe, et al.. (2007). Evidence for Genetic Susceptibility Towards Development of Posttransplant Lymphoproliferative Disorder in Solid Organ Recipients. Transplantation. 84(3). 387–391. 36 indexed citations
8.
Langrehr, Jan M., Markus Hammer, Manfred Lehmann, et al.. (2007). Short-Term Anti-CD4 Plus Anti-TNF-α Receptor Treatment in Allogeneic Small Bowel Transplantation Results in Long-Term Survival. Transplantation. 84(5). 639–646. 11 indexed citations
9.
Hammer, Markus, Gordon Brestrich, Andy Roemhild, et al.. (2007). Generation of EBV-specific T Cells for Adoptive Immunotherapy: A Novel Protocol Using Formalin-fixed Stimulator Cells to Increase Biosafety. Journal of Immunotherapy. 30(8). 817–824. 10 indexed citations
10.
11.
Hammer, Markus, Gordon Brestrich, Elisabeth Engelmann, et al.. (2006). HLA Type-Independent Method to Monitor Polyoma BK Virus-Specific CD4+ and CD8+T-Cell Immunity. American Journal of Transplantation. 6(3). 625–631. 58 indexed citations
12.
Nickel, Peter, Markus Hammer, Constanze Schönemann, et al.. (2006). Identification of Dialysis Patients with Panel-Reactive Memory T Cells before Kidney Transplantation Using an Allogeneic Cell Bank. Journal of the American Society of Nephrology. 17(2). 573–580. 56 indexed citations
13.
14.
Hammer, Markus, Gordon Brestrich, Andreas Moosmann, et al.. (2005). HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy. European Journal of Immunology. 35(7). 2250–2258. 27 indexed citations
15.
Babel, Nina, Markus Hammer, Christian Rosenberger, et al.. (2004). Treatment of Cytomegalovirus Disease with Valganciclovir in Renal Transplant Recipients: A Single Center Experience. Transplantation. 78(2). 283–285. 25 indexed citations
16.
Babel, Nina, Markus Hammer, & Petra Reinke. (2003). Adoptiver Transfer EBV-spezifischer T-Lymphozyten bei chronisch aktiver EBV-Infektion. DMW - Deutsche Medizinische Wochenschrift. 128(11). 548–550. 3 indexed citations
17.
Hammer, Markus, et al.. (2002). Antigen-Dependent Transgene Expression in Kidney Transplantation. Journal of the American Society of Nephrology. 13(2). 511–518. 5 indexed citations
18.
Hammer, Markus, Yuan Zhai, Masamichi Katori, et al.. (2001). Homing of In Vitro-Generated Donor Antigen-Reactive CD4+ T Lymphocytes to Renal Allografts Is α4β1 But Not αLβ2 Integrin Dependent. The Journal of Immunology. 166(1). 596–601. 11 indexed citations
19.
Zhai, Yuan, et al.. (2001). EVIDENCE OF T CELL CLONALITY IN THE INFECTIOUS TOLERANCE PATHWAY: IMPLICATIONS TOWARD IDENTIFICATION OF REGULATORY T CELLS1. Transplantation. 71(12). 1701–1708. 23 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellen Fietze Breakdown of academic impact, for papers by E. C. Benton Breakdown of academic impact, for papers by Fabrice Larosa Breakdown of academic impact, for papers by Dorothy Hui Lin Ng Breakdown of academic impact, for papers by Raymond C. Yu Breakdown of academic impact, for papers by B. Catteau Breakdown of academic impact, for papers by Takaharu Matsuyama Breakdown of academic impact, for papers by Susan DeWolf Breakdown of academic impact, for papers by Jennifer Cuellar‐Rodríguez Breakdown of academic impact, for papers by Marie‐Thérèse Rubio
Rankless by CCL
2026